ID: ALA295657

Max Phase: Preclinical

Molecular Formula: C25H23ClFN3O5S

Molecular Weight: 531.99

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1cn([C@@H]2O[C@H](CNC(=O)C3c4ccccc4Sc4c(Cl)cccc43)[C@@H](O)[C@@H]2F)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C25H23ClFN3O5S/c1-2-12-11-30(25(34)29-22(12)32)24-19(27)20(31)16(35-24)10-28-23(33)18-13-6-3-4-9-17(13)36-21-14(18)7-5-8-15(21)26/h3-9,11,16,18-20,24,31H,2,10H2,1H3,(H,28,33)(H,29,32,34)/t16-,18?,19+,20-,24-/m1/s1

Standard InChI Key:  ZZONCTBBLSRPDS-HYEGPKIMSA-N

Associated Targets(non-human)

TK Thymidine kinase (276 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK Thymidine kinase (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 531.99Molecular Weight (Monoisotopic): 531.1031AlogP: 2.76#Rotatable Bonds: 5
Polar Surface Area: 113.42Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.10CX Basic pKa: CX LogP: 3.36CX LogD: 3.36
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.47Np Likeness Score: -0.43

References

1. Martin JA, Lambert RW, Merrett JH, Parkes KE, Thomas GJ, Baker SJ, Bushnell DJ, Cansfield JE, Dunsdon SJ, Freeman AC, Hopkins RA, Johns IR, Keech E, Simmonite H, Walmsley A, Wong Kai-In P, Holland M..  (2001)  Nucleoside analogues as highly potent and selective inhibitors of herpes simplex virus thymidine kinase.,  11  (13): [PMID:11425530] [10.1016/s0960-894x(01)00256-6]

Source